IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Onesource Specialty Pharma

NSE:ONESOURCE · ISIN INE013P01021

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Onesource Specialty Pharma

Ratings & risks

Credit signals

Rating-action history

Agency evidence
CARE Ratings Limited rating actionCARE Ratings Limited · PDF preserved by IndiaTicker
Archived PDF
CARE Ratings Limited rating actionCARE Ratings Limited · PDF preserved by IndiaTicker
Archived PDF
CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source
CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source
CARE Ratings Limited · Stelis Biopharma LimitedCARE Ratings Limited · discovered
Agency source
CARE Ratings Limited · Stelis Biopharma LimitedCARE Ratings Limited · discovered
Agency source
CARE Ratings Limited · Stelis Biopharma LimitedCARE Ratings Limited · discovered
Agency source
CARE Ratings Limited · Stelis Biopharma Private LimitedCARE Ratings Limited · discovered
Agency source
CARE Ratings Limited · CARE assigns ‘CARE A (SO)’ ratings to the bank facilities of Stelis Biopharma P Ltd.CARE Ratings Limited · discovered
Agency source
Risk research framework

Questions to test against evidence

Analyst review
Operating deterioration

Track sector-specific operating metrics and reconcile them across reporting periods.

High
Funding and liquidity

Review debt maturity, repricing, liquidity and rating commentary where relevant.

High
Execution versus guidance

Compare management statements with subsequent reported delivery.

Medium
Governance and key-person change

Connect management transitions, related parties and auditor observations.

Medium